| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
71,277,000
|
56,900,000
|
46,232,000
|
37,233,000
| | Cost of Revenue | 3,337,000 | 2,867,000 | 2,411,000 | 1,263,000 | | |
Gross Profit
|
67,940,000
|
54,033,000
|
43,822,000
|
35,970,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 32,272,000 | 20,885,000 | 17,337,000 | 13,999,000 | | | |
Operating Income or Loss
|
39,004,000
|
36,016,000
|
28,895,000
|
23,234,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 39,004,000 | 36,016,000 | 28,895,000 | 23,234,000 |
|
Interest Expense | (13,250,000) | (13,713,000) | (11,240,000) | (10,639,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 5,854,000 | 5,380,000 | 2,821,000 | 2,526,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 20,409,000 | 16,906,000 | 14,485,000 | 12,294,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
20,409,000
|
16,906,000
|
14,485,000
|
12,294,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.30%